Literature DB >> 22650416

Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.

E Vidal1, J Torre-Cisneros, M Blanes, M Montejo, C Cervera, J M Aguado, O Len, J Carratalá, E Cordero, G Bou, P Muñoz, A Ramos, M Gurguí, N Borrell, J Fortún.   

Abstract

BACKGROUND: Urinary tract infection (UTI) is the most common infection in renal transplant patients, but it is necessary to determine the risk factors for bacterial UTI in recipients of other solid organ transplants (SOTs), as well as changes in etiology, clinical presentation, and prognosis.
METHODS: In total, 4388 SOT recipients were monitored in 16 transplant centers belonging to the Spanish Network for Research on Infection in Transplantation (RESITRA). The frequency and characteristics of bacterial UTI in transplant patients were obtained prospectively from the cohort (September 2003 to February 2005).
RESULTS: A total of 192 patients (4.4%) presented 249 episodes of bacterial UTI (0.23 episodes per 1000 transplantation days); 156 patients were kidney or kidney-pancreas transplant recipients, and 36 patients were liver, heart, and lung transplant recipients. The highest frequency was observed in renal transplants (7.3%). High frequency of cystitis versus pyelonephritis without related mortality was observed in both groups. The most frequent etiology was Escherichia coli (57.8%), with 25.7% producing extended-spectrum β-lactamase (ESBL). In all transplants but renal, most cases occurred in the first month after transplantation. Cases were uniformly distributed during the first 6 months after transplantation in renal recipients. Age (odds ratio [OR] per decade 1.1, 95% confidence interval [CI] 1.02-1.17), female gender (OR 1.74, 95% CI 1.42-2.13), and the need for immediate post-transplant dialysis (OR 1.63, 95% CI 1.29-2.05) were independent variables associated with bacterial UTI in renal and kidney-pancreas recipients. The independent risk factors identified in non-renal transplants were age (OR per decade 1.79, 95% CI 1.09-3.48), female gender (OR 1.7, 95% CI 1.43-2.49), and diabetes (OR 1.02, 95% CI 1.001-1.040).
CONCLUSIONS: UTI was frequent in renal transplants, but also not unusual in non-renal transplants. Because E. coli continues to be the most frequent etiology, the emergence of ESBL-producing strains has been identified as a new problem. In both populations, most cases were cystitis without related mortality. Although the first month after transplantation was a risk period in all transplants, cases were uniformly distributed during the first 6 months in renal transplants. Age and female gender were identified as risk factors for UTI in both populations. Other particular risk factors were the need for immediate post-transplant dialysis in renal transplants and diabetes in non-renal transplants.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22650416     DOI: 10.1111/j.1399-3062.2012.00744.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  28 in total

Review 1.  Bloodstream infections after solid-organ transplantation.

Authors:  Antonios Kritikos; Oriol Manuel
Journal:  Virulence       Date:  2016-01-14       Impact factor: 5.882

2.  Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.

Authors:  Zubair A Qureshi; Alveena Syed; Lloyd G Clarke; Yohei Doi; Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 3.  The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections.

Authors:  Brian Becknell; Megan Schober; Lindsey Korbel; John David Spencer
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-25       Impact factor: 5.091

4.  Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.

Authors:  Maristela P Freire; Edson Abdala; Maria L Moura; Flávio Jota de Paula; Fernanda Spadão; Hélio H Caiaffa-Filho; Elias David-Neto; William C Nahas; Ligia C Pierrotti
Journal:  Infection       Date:  2015-02-18       Impact factor: 3.553

5.  Infection-related hospitalizations after kidney transplantation in children: incidence, risk factors, and cost.

Authors:  Julien Hogan; Christine Pietrement; Anne-Laure Sellier-Leclerc; Ferielle Louillet; Rémi Salomon; Marie-Alice Macher; Etienne Berard; Cécile Couchoud
Journal:  Pediatr Nephrol       Date:  2017-07-25       Impact factor: 3.714

6.  Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study.

Authors:  Francesco Pesce; Marida Martino; Marco Fiorentino; Tiziana Rollo; Simona Simone; Pasquale Gallo; Giovanni Stallone; Giuseppe Grandaliano; Antonio Schena; Marcella Margiotta; Donata Mininni; Rita Palieri; Giuseppe Lucarelli; Michele Battaglia; Loreto Gesualdo; Giuseppe Castellano
Journal:  J Nephrol       Date:  2019-01-30       Impact factor: 3.902

Review 7.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 8.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients.

Authors:  John R Lee; Heejung Bang; Darshana Dadhania; Choli Hartono; Meredith J Aull; Michael Satlin; Phyllis August; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Transplantation       Date:  2013-10-27       Impact factor: 4.939

10.  Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Kidney Transplant Recipients.

Authors:  Belén Gutiérrez-Gutiérrez; Elena Pérez-Nadales; Salvador Pérez-Galera; Mario Fernández-Ruiz; Jordi Carratalà; Isabel Oriol; Elisa Cordero; José Antonio Lepe; Ban Hock Tan; Laura Corbella; Mical Paul; Alejandra M Natera; Miruna D David; Miguel Montejo; Ranganathan N Iyer; Ligia Camera Pierrotti; Esperanza Merino; Seema Mehta Steinke; Meenakshi M Rana; Patricia Muñoz; Alessandra Mularoni; Christian van Delden; Paolo Antonio Grossi; Elena María Seminari; Filiz Gunseren; Erika D Lease; Emmanuel Roilides; Jesús Fortún; Hande Arslan; Julien Coussement; Zeliha Koçak Tufan; Benoit Pilmis; Marco Rizzi; Belén Loeches; Britt Marie Eriksson; Edson Abdala; Fabio Soldani; Warren Lowman; Wanessa Trindade Clemente; Marta Bodro; María Carmen Fariñas; Esra Kazak; Luis Martínez-Martínez; José María Aguado; Julián Torre-Cisneros; Álvaro Pascual; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.